[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6271 followers
Created: 2025-07-28 07:07:56 UTC

🚀 3B BlackBio Dx Expands Global Reach with Strategic Acquisition of Coris Bioconcept | MCap XXXXXXXX Cr

- 3B BlackBio Dx Ltd. and subsidiary TRUPCR® Europe Limited to acquire XXX% of Coris Holding SRL for £2.15M upfront, with potential £0.615M earn-out.
- 3B acquires XX% stake; TPE takes 30%. Deal completion expected by September 10, 2025.
- Coris Bioconcept SRL, based in Belgium, specializes in IVD test kits with FY24 revenues of €5.22M and a XXXX% gross margin.
- Coris operates a XXXXX m² facility in Gembloux, Belgium, employing XX professionals.
- The 'HAT Sero K-SeT' test, part of Coris' portfolio, holds a global monopoly for detecting Trypanosoma brucei gambiense antibodies.
- Coris distributes products in over XX countries but reported a negative EBITDA of €0.215M in FY24.
- The acquisition aims to enhance 3B's product portfolio and leverage Coris' R&D and manufacturing capabilities.
- Both companies are ISO 13485 certified, with Coris founded in 1996 and 3B having 14+ years in IVD products.

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of X pages)

![](https://pbs.twimg.com/media/Gw7TmfxWYAARCFU.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949728514548117646/c:line.svg)

**Related Topics**
[belgium](/topic/belgium)
[mcap](/topic/mcap)
[acquisition](/topic/acquisition)
[dx](/topic/dx)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1949728514548117646)